China Cord Blood fiscal Q4 revenues up 7%; Net Income off 57%; CF Ops up 7%

• China Cord Blood (NYSE:CO) fiscal Q4 results ($M): Revenues: 26.3 (+7.3%); Operating Income: 8.0 (-22.7%); Net Income: 2.7 (-57.2%); CF Ops: 23.6 (+6.6%).
• New subscribers: 15,982; Accumulated subscriber base: 441,359.
• The company will host its conference call tomorrow morning at 8:00 am ET.
• Shares are up 3% after hours on light volume.